Antileukotriene drugs in the treatment of asthma.
نویسندگان
چکیده
Antileukotriene medications that have been implemented into clinical practice of bronchial asthma and allergic rhinitis include specific leukotriene receptor antagonists (montelukast, zafirlukast, pranlukast) and leukotriene biosynthesis inhibitors (zileuton). The current GINA (Global Initiative for Asthma) guidelines, the PRACTALL (Practicing Allergology) report on asthma treatment in children, and ARIA (Allergic Rhinitis and its Impact on Asthma) recommendations classify antileukotriene therapeutic agents as a group of drugs controlling the course of the disease. However, inhaled glucocorticosteroids still remain the first-line treatment in chronic asthma. According to current guidelines, antileukotriene drugs are recommended as alternative treatment to low-dose inhaled glucocorticosteroids in the second level of asthma severity and as complementary treatment to inhaled and/or oral glucocorticosteroids, starting from the third level of asthma severity. Recently, clinical efficacy of antileukotriene drugs has been suggested in the treatment of isolated allergic rhinitis, chronic cough in the course of asthma, as a sole symptom of the disease, and as the therapy for episodes of wheezing caused by viral infections.
منابع مشابه
آینده درمان دارویی آستم
ABSTRACT: Asthma is a chronic disease in which hyperactivity of airways to different stimuli is responsible for pathophysiologic changes seen. With respect to the pathophysiologic changes seen the treatment can be divided into two groups: bronchodilator and anti-inflammatory drugs. Bronchodilators consist of beta 2 agonists (salbutmol), Xanthine (theophilline) and anticholinergic(ipratropium)...
متن کاملLeukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review
In vitro and in vivo clinical and experimental data have suggested that leukotrienes play a key role in inflammatory reactions of the skin. Antileukotriene drugs, ie, leukotriene receptor antagonists and synthesis inhibitors, are a class of anti-inflammatory drugs that have shown clinical efficacy in the management of asthma and in rhinitis with asthma. We searched MEDLINE database and carried ...
متن کاملP10 - Antileukotriene treatment in children with bronchial asthma and allergic rhinitis
In recent years, scientists around the world are paying attention to the role of leukotrienes in the pathogenesis of bronchial asthma and allergic rhinitis. Leukotrienes – a group of biologically active substances produced from the metabolism of arachidonic acid. Increasing concentrations in the blood cause bronchoconstriction, increased bronchial secretion glands, increased vascular permeabili...
متن کاملOmalizumab: Current Status in Asthma Therapy
Bronchial asthma is characterised by inflammation in airways leading to hyperreactivity and spasm of the bronchial smooth muscle, oedema and disruption of the mucosa, and obstruction of the lumen by mucus. The drugs used for asthma are broadly classified into bronchodilators (reliever therapies) and anti-inflammatory drugs (preventer therapies). The preventer therapies mainly include corticoste...
متن کاملBronchial asthma, symptomatology and therapeutic method in traditional medicine
Precice information on the treatment of bronchial asthma in Persia up to 9th and 10th century is not available. However according to some old religious books like Yasna and Vendidad, the “Haoma” had been used in the treatment of perspiration disorders and its extract had been advised by Zoraster as sacred water. There are some interesting idea about treatment of thorax diseases, which consist: ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Polskie Archiwum Medycyny Wewnetrznej
دوره 120 3 شماره
صفحات -
تاریخ انتشار 2010